Massachusetts Selects Appriss' PMP Solutions to Enhance Interoperability
01 févr. 2016 12h09 HE
|
Appriss
LOUISVILLE, Ky., Feb. 1, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety, retail and healthcare, announced that it has signed an...
Vermont Adopts Appriss' Platform to Mitigate Drug Diversion
11 janv. 2016 11h05 HE
|
Appriss
LOUISVILLE, Ky., Jan. 11, 2016 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that the state of Vermont...
Kroger Introduces Appriss' NARxCHECK(TM) into Pharmacies
12 août 2015 11h51 HE
|
Appriss
LOUISVILLE, Ky., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and healthcare, announced that The Kroger Co. has...
Cerner Integrates NARxCHECK(TM) Into Electronic Health Record System
06 août 2015 10h30 HE
|
Appriss
LOUISVILLE, Ky., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Appriss Inc., a leading technology provider for risk assessment and analytics in public safety and health care, announced that Cerner (Nasdaq: CERN),...
NEXAFED(TM) Pseudoephedrine Tablets Disrupt Methamphetamine Production
02 mars 2012 06h30 HE
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Mar 2, 2012) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company innovating abuse deterrent drugs, today announced independent laboratory...
Acura Pharmaceuticals Provides Update on Opioid Product Licensed to Pfizer
17 oct. 2011 06h00 HE
|
Acura Pharmaceuticals
PALATINE, IL--(Marketwire - Oct 17, 2011) - Acura Pharmaceuticals, Inc. (NASDAQ: ACUR), a specialty pharmaceutical company, announced that they have been informed by Pfizer, Inc. (NYSE: PFE) that...